nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—Lamotrigine—SCN5A—dilated cardiomyopathy	0.0557	1	CrCbGaD
Triamterene—SCNN1G—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0385	0.0692	CbGpPWpGaD
Triamterene—SCNN1D—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0385	0.0692	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0385	0.0692	CbGpPWpGaD
Triamterene—SCNN1A—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0385	0.0692	CbGpPWpGaD
Triamterene—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0297	0.0766	CcSEcCtD
Triamterene—SCNN1A—Ion channel transport—RYR2—dilated cardiomyopathy	0.0251	0.0452	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—RYR2—dilated cardiomyopathy	0.0251	0.0452	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—RYR2—dilated cardiomyopathy	0.0251	0.0452	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—RYR2—dilated cardiomyopathy	0.0251	0.0452	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—PLN—dilated cardiomyopathy	0.0244	0.044	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—PLN—dilated cardiomyopathy	0.0244	0.044	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—PLN—dilated cardiomyopathy	0.0244	0.044	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—PLN—dilated cardiomyopathy	0.0244	0.044	CbGpPWpGaD
Triamterene—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0238	0.0613	CcSEcCtD
Triamterene—Azotaemia—Lisinopril—dilated cardiomyopathy	0.0232	0.0597	CcSEcCtD
Triamterene—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0215	0.0554	CcSEcCtD
Triamterene—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0205	0.0528	CcSEcCtD
Triamterene—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0136	0.0351	CcSEcCtD
Triamterene—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.0121	0.0313	CcSEcCtD
Triamterene—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.0117	0.03	CcSEcCtD
Triamterene—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0109	0.028	CcSEcCtD
Triamterene—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0108	0.0278	CcSEcCtD
Triamterene—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0106	0.0272	CcSEcCtD
Triamterene—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0102	0.0263	CcSEcCtD
Triamterene—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00971	0.025	CcSEcCtD
Triamterene—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00943	0.0243	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00875	0.0157	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00875	0.0157	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00875	0.0157	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00875	0.0157	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00851	0.0153	CbGpPWpGaD
Triamterene—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00795	0.0205	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00791	0.0142	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00791	0.0142	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00791	0.0142	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00791	0.0142	CbGpPWpGaD
Triamterene—SCNN1A—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.0076	0.0137	CbGpPWpGaD
Triamterene—SCNN1G—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.0076	0.0137	CbGpPWpGaD
Triamterene—SCNN1D—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.0076	0.0137	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.0076	0.0137	CbGpPWpGaD
Triamterene—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00738	0.019	CcSEcCtD
Triamterene—Dizziness—Spironolactone—dilated cardiomyopathy	0.00714	0.0184	CcSEcCtD
Triamterene—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00707	0.0182	CcSEcCtD
Triamterene—Vomiting—Spironolactone—dilated cardiomyopathy	0.00686	0.0177	CcSEcCtD
Triamterene—Rash—Spironolactone—dilated cardiomyopathy	0.00681	0.0175	CcSEcCtD
Triamterene—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0068	0.0175	CcSEcCtD
Triamterene—Headache—Spironolactone—dilated cardiomyopathy	0.00676	0.0174	CcSEcCtD
Triamterene—Jaundice—Lisinopril—dilated cardiomyopathy	0.00673	0.0174	CcSEcCtD
Triamterene—Nausea—Spironolactone—dilated cardiomyopathy	0.00641	0.0165	CcSEcCtD
Triamterene—Dry mouth—Furosemide—dilated cardiomyopathy	0.00599	0.0154	CcSEcCtD
Triamterene—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00587	0.0151	CcSEcCtD
Triamterene—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00575	0.0148	CcSEcCtD
Triamterene—Fatigue—Furosemide—dilated cardiomyopathy	0.00506	0.013	CcSEcCtD
Triamterene—SCNN1B—Ion channel transport—RAF1—dilated cardiomyopathy	0.00496	0.00891	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—RAF1—dilated cardiomyopathy	0.00496	0.00891	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—RAF1—dilated cardiomyopathy	0.00496	0.00891	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—RAF1—dilated cardiomyopathy	0.00496	0.00891	CbGpPWpGaD
Triamterene—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00449	0.0116	CcSEcCtD
Triamterene—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00441	0.0114	CcSEcCtD
Triamterene—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00433	0.0111	CcSEcCtD
Triamterene—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00431	0.0111	CcSEcCtD
Triamterene—Asthenia—Furosemide—dilated cardiomyopathy	0.00421	0.0109	CcSEcCtD
Triamterene—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00402	0.0104	CcSEcCtD
Triamterene—Dizziness—Furosemide—dilated cardiomyopathy	0.00388	0.01	CcSEcCtD
Triamterene—Fatigue—Lisinopril—dilated cardiomyopathy	0.0038	0.00979	CcSEcCtD
Triamterene—Vomiting—Furosemide—dilated cardiomyopathy	0.00373	0.00962	CcSEcCtD
Triamterene—Rash—Furosemide—dilated cardiomyopathy	0.0037	0.00954	CcSEcCtD
Triamterene—Dermatitis—Furosemide—dilated cardiomyopathy	0.0037	0.00953	CcSEcCtD
Triamterene—Headache—Furosemide—dilated cardiomyopathy	0.00368	0.00948	CcSEcCtD
Triamterene—Nausea—Furosemide—dilated cardiomyopathy	0.00349	0.00899	CcSEcCtD
Triamterene—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00325	0.00836	CcSEcCtD
Triamterene—Asthenia—Lisinopril—dilated cardiomyopathy	0.00316	0.00815	CcSEcCtD
Triamterene—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00301	0.00777	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00293	0.00527	CbGpPWpGaD
Triamterene—Dizziness—Lisinopril—dilated cardiomyopathy	0.00291	0.00751	CcSEcCtD
Triamterene—Vomiting—Lisinopril—dilated cardiomyopathy	0.0028	0.00722	CcSEcCtD
Triamterene—Rash—Lisinopril—dilated cardiomyopathy	0.00278	0.00716	CcSEcCtD
Triamterene—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00278	0.00715	CcSEcCtD
Triamterene—Headache—Lisinopril—dilated cardiomyopathy	0.00276	0.00711	CcSEcCtD
Triamterene—Nausea—Lisinopril—dilated cardiomyopathy	0.00262	0.00674	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00173	0.0031	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00173	0.0031	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00173	0.0031	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00173	0.0031	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00135	0.00243	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0013	0.00233	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000845	0.00152	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000803	0.00144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000755	0.00136	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000579	0.00104	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000579	0.00104	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000552	0.000992	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000552	0.000992	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000358	0.000643	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000336	0.000605	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000304	0.000547	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000186	0.000334	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000181	0.000325	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000163	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	8.26e-05	0.000149	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	8.05e-05	0.000145	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	7.25e-05	0.00013	CbGpPWpGaD
